ACTRN12622001337763招募中未知
The Potential Benefits of Ginger Supplementation in Individuals With Iron Deficiency: a Randomised Controlled Pilot Study
The Oaks Medical Practice0 个研究点目标入组 20 人开始时间: 2022年10月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit(—)
- 性别
- All
入选标准
- •1. Adults aged 18 and over
- •2. Confirmed iron deficiency (ID) diagnosis with SF level less than 30 µg/L with normal or slightly lower than normal Hb level (Hb greater than or equal to 110 g/L)
- •3. Adequately maintained liver and renal functions with the following laboratory
- •parameters less than 2x Upper Limit of Normal:
- •a. Alanine transaminase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl transferase (GGT)
- •b. Blood urea nitrogen (BUN) and creatinine
- •4. Functional grade based on ECOG Performance Status is between 0 to 2
- •5. Received explanation of the purpose and methods of the study and provided written
- •consent at the point of recruitment
排除标准
- •1. A mental health condition that may impede the patient’s ability to provide informed consent
- •2. Having diagnosed with an eating disorder or demonstrating certain behavioural, physical and psychological signs or changes that often accompany an eating disorder
- •3. Known or possible pregnancy, desire to become pregnant during the study period, or currently breastfeeding
- •4. Known to have an allergy to ginger or had experienced adverse reactions to ginger previously
- •5. Underwent any major surgery within 6 months at the time of screening or planning to undergo a major surgery during the study period
- •6. Had any blood transfusion to replace blood lost due to surgery or injury within the last 6 months or need to receive a blood transfusion during the study period
- •7. Having underlying pathology and sources of overt and occult blood loss (e.g., GIT, genitourinary, nose, mouth, etc.) that was diagnosed or currently under investigation
- •8. Donating blood within 8 weeks of starting the trial or during the study period
- •9. Having underlying conditions due to chronic disease (e.g. inflammatory bowel disease, celiac disease, autoimmune gastritis, rheumatoid arthritis, etc.), liver disease, B12 deficiency, or malignancy
- •10. Having active infections or other medical conditions that elevate SF and high sensitivity C-reactive protein (hsCRP) acutely
- •11. Previous treatment of ID with oral iron therapy within the last 1 month or intravenous iron therapy within the last 3 months
- •12. Currently on warfarin or any other blood-thinning medications (anticoagulants)
- •13. No concurrently taking other dietary supplement of iron, vitamin C, probiotics, vitamin B12, folic acid, and vitamin D during the trial
研究者
相似试验
已完成
不适用
The effect of Ginger powder consumption on some genes expression that are mediators of immunity and inflammation in adult with Rheumatoid Arthritisadult active Rheumatoid arthritis.Rheumatoid arthritis, unspecifiedIRCT201403109472N6Vice-chancellor for Research, Iran University of Medical Sciences70
招募中
不适用
Evaluation of the effect of ginger supplementation on clinical outcomes, serum levels of some inflammatory markers, TAC and expression of mir-21 in patients with active ulcerative colitislcerative colitis.Ulcerative colitisIRCT20190129042552N1Ahvaz University of Medical Sciences44
招募中
不适用
Evaluation of the Efficacy of Ginger Supplementation with Pellet Formulation in Children with Juvenile Idiopathic Arthritis(JIA)Juvenile arthritisjuvenile idiopathic arthritis (JIA).IRCT20191221045837N4Mashhad University of Medical Sciences50
已完成
2 期
Effect of ginger supplementation in treatment of type 2 diabetic patients with chronic periodontitisIRCT20170304032874N2Ahvaz University of Medical Sciences46
尚未招募
3 期
The Effect of Ginger supplementation and high intensity Interval Training on metabolic status, serum irisin and anthropometric indices in obese meIRCT20100408003664N20utritional Reseach Center of Tabriz University of Medical Sciences64
